Serum concentrations of VCAM-1, P-selectin, and ICAM-1 Are Downregulated during CPDA-1 storage of Whole Blood

Blood banks are the quiet guardians of modern medicine, holding life-saving units of blood in refrigerated storage until a patient needs them. For decades, the focus has been on keeping the red cells alive and free from infection. However, blood is not a static fluid; it is a living tissue that continues to change the moment it is drawn from a donor. As it sits in a bag, waiting to be transfused, it undergoes a slow transformation known as a "storage lesion." These changes involve the breakdown of cells and the release of chemical signals that can alter how the blood behaves once it enters a new body. Among the most important of these signals are adhesion molecules. Think of these molecules as tiny, sticky hands on the surface of cells that help them grab onto one another or onto the walls of blood vessels. They are essential for the body's immune system to find trouble spots and for blood to clot when necessary. But when blood is stored for weeks, the behavior of these sticky hands changes, and scientists have long wondered exactly how.

A team of researchers at Rivers State University in Port Harcourt, Nigeria, set out to track these changes in real time. They were interested in three specific types of these sticky molecules: VCAM-1, ICAM-1, and P-selectin. These molecules act as markers of inflammation and cell activity, and their levels in the blood can tell a story about the health of the vessel walls and the immune system. The researchers wanted to know if the act of storing blood in a standard preservative solution called CPDA-1 caused these molecules to disappear, increase, or stay the same over the course of a month. To find out, they collected whole blood from forty healthy male volunteers. The donors were screened to ensure they were free of common infections, and their blood was divided into units based on their blood type: A, B, AB, and O. Each unit was placed in a blood bag with the preservative solution and kept in a refrigerator at a cool, steady temperature, mimicking the conditions of a real blood bank.

The scientists did not just look at the blood once; they treated the storage period as a timeline. They carefully drew small samples from the blood bags on the first day, and then again on days eight, fifteen, twenty-two, and twenty-nine. For each sample, they separated the liquid part of the blood and measured the exact amount of the three adhesion molecules present. The results revealed a clear and consistent pattern. For almost every blood type and every molecule tested, the concentration of these sticky hands dropped significantly as the days passed. The levels were highest when the blood was fresh and fell steadily as the storage time increased. By the twenty-second day, the amounts of these molecules had decreased dramatically compared to the first day. This decline suggests that the storage process itself causes these important signaling proteins to break down or become less available, rather than being released in greater numbers as the blood ages.

There was one small exception to this steady decline. In the blood units from donors with type B blood, the level of VCAM-1 actually rose slightly on the eighth day before beginning its long descent. This temporary bump suggests that the storage environment might trigger a brief, early reaction in some blood types before the molecules eventually degrade. However, for the other molecules and the other blood types, the story was one of continuous loss. The researchers also looked at how these molecules related to one another. They found that VCAM-1 and ICAM-1 moved in lockstep; when one went down, the other went down with it, suggesting they are affected by the same storage conditions. In contrast, P-selectin did not follow the same tight pattern, indicating it is regulated differently or comes from a different source within the stored blood.

The study concludes that the longer whole blood sits in storage, the fewer of these critical adhesion molecules remain in the fluid. This finding matters because these molecules play a key role in how blood interacts with the body's blood vessels and immune system. If a patient receives a unit of blood that has been stored for a long time, they are receiving blood with lower levels of these signaling proteins than what was present when the blood was first collected. This change could potentially influence how the transfused blood functions or how the recipient's body reacts to it. The research provides a clearer picture of the invisible chemical shifts that happen in a blood bag, reminding us that even preserved blood is a dynamic system that changes with time.